Back to Journals » OncoTargets and Therapy » Volume 11

TIM-3, a promising target for cancer immunotherapy

Total article views   HTML views PDF downloads Totals
35,651 Dovepress* 14,631+ 2,167 16,798
PubMed Central* 21,020 2,859 23,879
Totals 35,651 5,026 40,677
*Since 16 October 2018
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 1 5

View citations on PubMed Central and Google Scholar